[1]
Wareham, L.K.; Liddelow, S.A.; Temple, S.; Benowitz, L.I.; Di Polo, A.; Wellington, C.; Goldberg, J.L.; He, Z.; Duan, X.; Bu, G.; Davis, A.A.; Shekhar, K.; Torre, A.; Chan, D.C.; Canto-Soler, M.V.; Flanagan, J.G.; Subramanian, P.; Rossi, S.; Brunner, T.; Bovenkamp, D.E.; Calkins, D.J. Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol. Neurodegener., 2022, 17(1), 23.
[2]
Calkins, D.J. Adaptive responses to neurodegenerative stress in glaucoma. Prog. Retin. Eye Res., 2021, 84, 100953.
[3]
Baratta, R.O.; Schlumpf, E.; Buono, B.J.D.; DeLorey, S.; Calkins, D.J. Corneal collagen as a potential therapeutic target in dry eye disease. Surv. Ophthalmol., 2022, 67(1), 60-67.
[4]
Lambert, W.S.; Carlson, B.J.; Ghose, P.; Vest, V.D.; Yao, V.; Calkins, D.J. Towards a microbead occlusion model of glaucoma for a non-human primate. Sci. Rep., 2019, 9(1), 11572.
[5]
Risner, M.L.; Pasini, S.; McGrady, N.R.; Calkins, D.J. Bax contributes to retinal ganglion cell dendritic degeneration during glaucoma. Mol. Neurobiol., 2022, 59(3), 1366-1380.
[6]
Taiel, M.; Sahel, J.A.; Calkins, D.J. Ocular stress enhances contralateral transfer of lenadogene nolparvovec gene therapy through astrocyte networks. Mol. Ther., 2023, 31(7), 2005-2013.
[7]
McGrady, N.R.; Boal, A.M.; Risner, M.L.; Cooper, M.L.; Pasini, S.; Lambert, W.S.; D’Alessandro, K.B.; Yao, V.; Risner, M.L.; Calkins, D.J. Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress. Proc. Natl. Acad. Sci. U.S.A, 2020, 117(31), 18810-18821.
